Literature DB >> 21773969

Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer.

Feng Zhou1, Xianli He, Hanqiang Liu, Yong Zhu, Tianbo Jin, Chao Chen, Falin Qu, Yunming Li, Guoqiang Bao, Zhinan Chen, Jinliang Xing.   

Abstract

BACKGROUND: Previous studies have demonstrated that circadian genes play a role in the development and progression of many cancers. This study aims to assess the effects of single nucleotide polymorphisms (SNPs) in circadian genes on recurrence and survival of colorectal cancer (CRC) patients.
METHODS: Nine functional SNPs in 3 genes (CLOCK, NPAS2, and BMAL1) on the circadian positive feedback loop were selected and genotyped using the Sequenom iPLEX genotyping system in a cohort of 411 resected Chinese CRC patients. Multivariate Cox proportional hazards model and Kaplan-Meier curve were used for the prognosis analysis.
RESULTS: The authors identified 2 SNPs in the CLOCK gene to be significantly associated with CRC overall survival. SNP rs3749474 exhibited a significant association with survival of CRC patients in the additive model (hazard ratio [HR], 0.55; 95% confidence interval [CI], 0.37-0.81; P = .003). In addition, patients carrying the heterozygous variant of rs1801260 had significantly increased overall survival compared with those carrying homozygous wild-type genotype (HR, 0.31; 95% CI, 0.11-0.88; P = .03). Findings from functional assay provided further biological support for these significant associations. Stratified analysis found no modifying effect of chemotherapy on the prognostic significance of both SNPs. Moreover, we observed cumulative effects of these 2 SNPs on CRC overall survival (P for trend = .01). Compared with patients carrying no unfavorable genotypes, those carrying 2 unfavorable genotypes had a 2.92-fold increased risk of death (P = .03).
CONCLUSIONS: The results suggest for the first time that CLOCK gene polymorphisms may serve as an independent prognostic marker for CRC patients.
Copyright © 2011 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21773969     DOI: 10.1002/cncr.26348

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  24 in total

1.  Pharmacokinetics of Irinotecan, Oxaliplatin and 5-Fluorouracil During Hepatic Artery Chronomodulated Infusion: A Translational European OPTILIV Study.

Authors:  Francis Lévi; Abdoulaye Karaboué; Marie-Christine Etienne-Grimaldi; Gilles Paintaud; Christian Focan; Pasquale Innominato; Mohamed Bouchahda; Gérard Milano; Etienne Chatelut
Journal:  Clin Pharmacokinet       Date:  2017-02       Impact factor: 6.447

2.  Effect of thymidylate synthase gene polymorphism on the response to chemotherapy and clinical outcome of non-small cell lung cancer patients.

Authors:  Honglin Dong; Dengke Bao; Xu Guo; Jie Hu; Xiaofei Li; Shaogui Wan; Jinliang Xing
Journal:  Tumour Biol       Date:  2015-04-16

Review 3.  Diversity of human clock genotypes and consequences.

Authors:  Luoying Zhang; Louis J Ptáček; Ying-Hui Fu
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

Review 4.  Genetic variations in colorectal cancer risk and clinical outcome.

Authors:  Kejin Zhang; Jesse Civan; Sushmita Mukherjee; Fenil Patel; Hushan Yang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

5.  Functional polymorphisms of circadian negative feedback regulation genes are associated with clinical outcome in hepatocellular carcinoma patients receiving radical resection.

Authors:  Zhaohui Zhang; Fei Ma; Feng Zhou; Yibing Chen; Xiaoyan Wang; Hongxin Zhang; Yong Zhu; Jianwei Bi; Yiguan Zhang
Journal:  Med Oncol       Date:  2014-10-26       Impact factor: 3.064

Review 6.  Clock genes: their role in colorectal cancer.

Authors:  Theodoros Karantanos; George Theodoropoulos; Dimitrios Pektasides; Maria Gazouli
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

Review 7.  Understanding the significance of biological clock and its impact on cancer incidence.

Authors:  Shalie Malik; James Stokes Iii; Upender Manne; Rajesh Singh; Manoj K Mishra
Journal:  Cancer Lett       Date:  2021-12-11       Impact factor: 8.679

Review 8.  The circadian clock in cancer development and therapy.

Authors:  Loning Fu; Nicole M Kettner
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

9.  Circadian pathway genes in relation to glioma risk and outcome.

Authors:  Melissa H Madden; Gabriella M Anic; Reid C Thompson; L Burton Nabors; Jeffrey J Olson; James E Browning; Alvaro N Monteiro; Kathleen M Egan
Journal:  Cancer Causes Control       Date:  2013-10-18       Impact factor: 2.506

10.  Differences in circadian rhythmicity in CLOCK 3111T/C genetic variants in moderate obese women as assessed by thermometry, actimetry and body position.

Authors:  C Bandín; A Martinez-Nicolas; J M Ordovás; J A Ros Lucas; P Castell; T Silvente; J A Madrid; M Garaulet
Journal:  Int J Obes (Lond)       Date:  2012-11-20       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.